Antibody Testing in Peripheral Neuropathies

Neurologic Clinics

Volumn 25, Issue 1, 2007, Pages 29-46

  Vernino, Steven ^a   Wolfe, Gil I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; GLYCOPROTEIN; HU ANTIBODY; POLYCLONAL ANTIBODY; SULFATIDE;

AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; CELIAC DISEASE; DISEASE ASSOCIATION; GLYCOSYLATION; HUMAN; IMMUNOASSAY; MOTOR NEUROPATHY; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SJOEGREN SYNDROME; VASCULITIS;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CELIAC DISEASE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELIN-ASSOCIATED GLYCOPROTEIN; PERIPHERAL NERVOUS SYSTEM DISEASES; SJOGREN'S SYNDROME; SJOGREN-LARSSON SYNDROME;

EID: 33847139408     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2006.10.002     Document Type: Review

References (72)

1. Adams D., Kuntzer T., Burger D., et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 32 (1991) 223-230
2. Pestronk A., Cornblath D.R., Ilyas A.A., et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24 (1988) 73-78
3. Pestronk A., Lopate G., Kornberg A.J., et al. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 44 (1994) 2027-2031
4. Jacobs B.C., van Doorn P.A., Schmitz P.I., et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol 40 (1996) 181-187
5. van den Berg L.H., Marrink J., de Jager A.E., et al. Anti-GM1 antibodies in patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 55 (1992) 8-11
6. Yu Z., Kryzer T.J., Griesmann G.E., et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49 (2001) 146-154
7. Lucchinetti C.F., Kimmel D.W., and Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50 (1998) 652-657
8. Grant I.A., Hunder G.G., Homburger H.A., et al. Peripheral neuropathy associated with sicca complex. Neurology 48 (1997) 855-862
9. Chin R.L., Sander H.W., Brannagan T.H., et al. Celiac neuropathy. Neurology 60 (2003) 1581-1585
10. Asbury A.K. Gangliosides and peripheral neuropathies: an overview. Prog Brain Res 101 (1994) 279-287
11. Parry G.J. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 17 (1994) 97-99
12. Sillevis Smitt P.A., Manley G.T., and Posner J.B. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45 (1995) 1873-1878
13. Kusunoki S., Hitoshi S., Kaida K.-I., et al. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol 45 (1999) 400-403
14. Yuki N., Yamada M., Koga M., et al. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 (2001) 712-720
15. Steck A.J., Burger D., Picasso S., et al. Gangliosides and related glycoconjugates in myelin: relationship to peripheral neuropathies. Prog Brain Res 101 (1994) 305-312
16. Yuki N., Taki T., Takahashi M., et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 36 (1994) 791-793
17. Ang C.W., Laman J.D., Willison H.J., et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barre and Miller Fisher patients. Infect Immun 70 (2002) 1202-1208
18. Latov N., Sherman W.H., Nemni R., et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med 303 (1980) 618-621
19. Ilyas A.A., Quarles R.H., Dalakas M.C., et al. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 18 (1985) 655-659
20. Nobile-Orazio E., Manfredini E., Carpo M., et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36 (1994) 416-424
21. Van den Berg L., Hays A.P., Nobile-Orazio E., et al. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19 (1996) 637-643
22. Pestronk A., Li F., Griffin J., et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 41 (1991) 357-362
23. Gosselin S., Kyle R.A., and Dyck P.J. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 30 (1991) 54-61
24. Freddo L., Yu R.K., Latov N., et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36 (1986) 454-458
25. Krarup C., Stewart J.D., Sumner A.J., et al. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40 (1990) 118-127
26. Chaudhry V., Corse A.M., Cornblath D.R., et al. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 17 (1994) 198-205
27. Katz J.S., Wolfe G.I., Bryan W.W., et al. Electrophysiologic findings in multifocal motor neuropathy. Neurology 48 (1997) 700-707
28. Wolfe G.I., El-Feky W.H., Katz J.S., et al. Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve 20 (1997) 1275-1283
29. Pestronk A., and Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 49 (1997) 1289-1292
30. Taylor B.V., Gross L., and Windebank A.J. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 47 (1996) 951-955
31. Pestronk A., Adams R.N., Clawson L., et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 38 (1988) 1457-1461
32. van Sorge N.M., van der Pol W.L., Jansen M.D., et al. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barre syndrome. Autoimmun Rev 3 (2004) 61-68
33. Khalili-Shirazi A., Gregson N., Gray I., et al. Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection. J Neurol Neurosurg Psychiatry 66 (1999) 376-379
34. Yuki N., and Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 154 (1998) 14-17
35. Daune G.C., Farrer R.G., Dalakas M.C., et al. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol 31 (1992) 683-685
36. Dalakas M.C., and Quarles R.H. Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?. Ann Neurol 39 (1996) 419-422
37. Nardelli E., Steck A.J., Barkas T., et al. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol 23 (1988) 524-528
38. Yuki N., Yoshino H., Sato S., et al. Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15 (1992) 899-903
39. Ho T.W., Willison H.J., Nachamkin I., et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol 45 (1999) 168-173
40. Willison H.J. The immunobiology of Guillain-Barre syndromes. J Peripher Nerv Syst 10 (2005) 94-112
41. Chiba A., Kusunoki S., Obata H., et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 43 (1993) 1911-1917
42. Yuki N., Sato S., Tsuji S., et al. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43 (1993) 414-417
43. Willison H.J., Veitch J., Paterson G., et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56 (1993) 204-206
44. Carpo M., Pedotti R., Allaria S., et al. Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168 (1999) 78-84
45. Yuki N., Sato S., Tsuji S., et al. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci 118 (1993) 83-87
46. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 39 (1996) 668-672
47. Nemni R., Fazio R., Quattrini A., et al. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol 43 (1993) 79-85
48. Notermans N.C., Wokke J.H., Franssen H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56 (1993) 1066-1071
49. Lopate G., Parks B.J., Goldstein J.M., et al. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry 62 (1997) 581-585
50. Dabby R., Weimer L.H., Hays A.P., et al. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology 54 (2000) 1448-1452
51. Pestronk A., Choksi R., Bieser K., et al. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein. Muscle Nerve 17 (1994) 1293-1300
52. Antoine J.C., Mosnier J.F., Absi L., et al. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 67 (1999) 7-14
53. Peterson K., Forsyth P.A., and Posner J.B. Paraneoplastic sensorimotor neuropathy associated with breast cancer. J Neurooncol 21 (1994) 159-170
54. Elrington G.M., Murray N.M., Spiro S.G., et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 54 (1991) 764-767
55. Dalmau J., Graus F., Rosenblum M., et al. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 71 (1992) 59-72
56. Auger R.G., Windebank A.J., Lucchinetti C.F., et al. Role of the blink reflex in the evaluation of sensory neuronopathy. Neurology 53 (1999) 407-408
57. Vernino S., Low P.A., Fealey R.D., et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 (2000) 847-855
58. Candler P.M., Hart P.E., Barnett M., et al. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 75 (2004) 1411-1415
59. Lawn N.D., Westmoreland B.F., Kiely M.J., et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78 (2003) 1363-1368
60. Dalmau J., Furneaux H.M., Gralla R.J., et al. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol 27 (1990) 544-552
61. Pittock S.J., Kryzer T.J., and Lennon V.A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56 (2004) 715-719
62. Younes-Mhenni S., Janier M.F., Cinotti L., et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127 Pt 10 (2004) 2331-2338
63. Gill S., Murray N., Dalmau J., et al. Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer. Can J Neurol Sci 30 (2003) 269-271
64. Honnorat J., Byk T., Kusters I., et al. Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur J Neurosci 11 (1999) 4226-4232
65. Vernino S., and Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10 (2004) 7270-7275
66. Font J., Ramos-Casals M., de la Red G., et al. Pure sensory neuropathy in primary Sjogren's syndrome. Longterm prospective followup and review of the literature. J Rheumatol 30 (2003) 1552-1557
67. Naito Y., Matsumoto I., Wakamatsu E., et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann Rheum Dis 64 (2005) 510-511
68. Farrell R.J., and Kelly C.P. Celiac sprue. N Engl J Med 346 (2002) 180-188
69. Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352 (1998) 1582-1585
70. Volta U., De Giorgio R., Granito A., et al. Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis 38 (2006) 183-187
71. Alaedini A., Green P.H., Sander H.W., et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol 127 (2002) 145-148
72. Schroeder C., Vernino S., Birkenfeld A.L., et al. Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353 (2005) 1585-1590